Pharming (PHAR) Convertible Debt (2020 - 2026)
Powered by 
Analysis
Pharming (PHAR) Convertible Debt (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Pharming | 794.84 Mn | 635.34 Mn | 141.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.40 Mn |
| Mar 31, 2026 | 93.39 Mn |
| Dec 31, 2025 | 92.72 Mn |
| Sep 30, 2025 | 93.14 Mn |
| Mar 31, 2025 | 83.85 Mn |
| Dec 31, 2024 | 78.15 Mn |
| Sep 30, 2024 | 92.10 Mn |
| Jun 30, 2024 | 87.32 Mn |
| Dec 31, 2023 | 136.60 Mn |
| Sep 30, 2023 | 129.73 Mn |
| Jun 30, 2023 | 134.18 Mn |
| Mar 31, 2023 | 133.58 Mn |
| Dec 31, 2022 | 131.62 Mn |
| Sep 30, 2022 | 120,005.00 |
| Jun 30, 2022 | 128.24 Mn |
| Mar 31, 2022 | 135.56 Mn |
| Dec 31, 2021 | 140,303.46 |
| Sep 30, 2021 | 140.96 Mn |
| Jun 30, 2021 | 145.44 Mn |
| Mar 31, 2021 | 141,169.00 |